L. F. Tietze et al.
FULL PAPER
was quenched by addition of triethylamine (100 mL) and the mixture
poured into water (5 mL). The organic phase was separated and the
aqueous phase extracted with CH2Cl2 (2 Â 5 mL). The combined organic
phases were washed with brine, dried over Na2SO4, and concentrated in
vacuo. Purification of the residue by column chromatography (n-pentane/
tert-butyl methyl ether 15:1) gave the corresponding homoallylic ethers
16a ± d, 17a ± d, 19a ± d, 20a ± d, 22b ± d, 29a ± d/29-ent-a ± d, and 30a ± d/
30-ent-a ± d, respectively.
(4R,6R,1'R,2'R)-4-Methyl-4-(2'-trifluoroacetamido-1'-phenyl-propoxy)-6-
(tert-butyldiphenylsilanyloxy)-hept-1-ene (19c): According to the general
procedure, reaction of ketone 8c (170 mg, 0.50 mmol) with ent-2 (80 mg,
0.25 mmol) gave the homoallylic ether 19c (69 mg, 0.11 mmol, 44%) as
colorless needles, along with recovered ent-2 (30 mg, 0.09 mmol, 35%).
M.p. 778C (pentane); [a]D20 ꢁ20.08 (c 0.5, CHCl3); 1H NMR (200 MHz,
CDCl3): d 0.84 (s, 3H), 1.11 (d, J 7.0 Hz, 3H), 1.14 (d, J 7.0 Hz, 3H),
1.19 (dd, J1 14.5 Hz, J2 4.0 Hz, 1H), 1.97 (dd, J1 14.5 Hz, J2 8.5 Hz,
1H), 2.28 (ddd, J1 1.0 Hz, J2 7.0 Hz, J3 13.5 Hz, 1H), 2.36 (dd, J1
1.0 Hz, J2 7.5 Hz, J3 13.5 Hz, 1H), 2.90 (m, 1H), 4.01 (m, 1H), 4.55 (d,
J 4.0 Hz, 1H), 5.02 ± 5.12 (m, 2H), 5.67 ± 5.81 (m, 1H), 6.30 (brd, J
8.0 Hz, 1H), 7.10 ± 7.33 (m, 10H); 13C NMR (50.3 MHz, CDCl3): d 16.73,
19.09, 23.55, 25.67, 26.96, 44.47, 49.81, 51.68, 67.11, 74.27, 78.28, 115.8 (q,
1JCF 288 Hz), 118.2, 126.6, 127.4, 127.5, 128.6, 129.4, 129.6, 134.1, 141.1,
(4R,1'R,2'R,1''R,3''R,4''R)-4-(2'-Trifluoroacetamido-1'-phenyl-propoxy)-
4-(3''-tert-butyldiphenylsilanyloxy-4''-methyl-cyclohexyl)-pent-1-ene
(19a): According to the general procedure, reaction of ketone 8a (197 mg,
0.50 mmol) with ent-2 (80 mg, 0.25 mmol) gave the homoallylic ether 19a
(106 mg, 0.16 mmol, 64%) as colorless needles, along with recovered ent-2
(20 mg, 0.06 mmol, 20%). M.p. 1818C (pentane); [a]2D0 ꢁ29.08 (c 0.5,
CHCl3); 1H NMR (200 MHz, CDCl3): d 0.49 (s, 3H), 0.64 ± 1.77 (m, 8H),
0.99 (d, J 6.5 Hz, 3H), 1.03 (s, 9H), 1.09 (d, J 7.2 Hz, 3H), 2.06 (dd, J1
7.0 Hz, J2 15.0 Hz, 1H), 2.31 (dd, J1 7.5 Hz, J2 15.0 Hz, 1H), 3.14 ± 3.24
(m, 1H), 4.07 (m, 1H), 4.48 (d, J 3.7 Hz, 1H), 4.86 ± 5.01 (m, 2H), 5.45 ±
5.61 (m, 1H), 6.26 (brd, J 8.0 Hz, 1H), 7.08 ± 7.74 (m, 15H); 13C NMR
(50.3 MHz, CDCl3): d 16.41, 19.23, 19.50, 21.70, 25.88, 27.08, 32.99, 36.69,
40.60, 40.64, 44.10, 51.59, 73.90, 78.51, 79.94, 115.8 (q, 1JCF 289 Hz), 117.9,
126.7, 127.3, 127.4, 127.7, 128.2, 129.3, 129.4, 133.6, 135.9, 141.1, 156.3 (q,
2JCF 37 Hz); IR (KBr): nÄ 3312, 3110, 3074, 3048, 3030, 2962, 2936, 2868,
2865, 1706, 1208, 1188, 1162, 1110, 1092, 1058, 914, 758, 702 cmꢁ1; MS:
2
156.0 (q, JCF 37 Hz); IR (KBr): nÄ 3302, 3106, 3072, 3044, 2964, 2934,
2896, 2858, 1702, 1214, 1186, 1164, 1108, 1066, 916, 760, 704 cmꢁ1; MS
(70 eV, CI): m/z (%): 629 (100) [MNH3H] ; C35H44F3NO3Si (611.82):
calcd C 68.71, H 7.24; found C 68.63, H 7.41.
(4S,6R,1'S,2'S)-4-Methyl-4-(2'-trifluoroacetamido-1'-phenyl-propoxy)-6-
(tert-butyldiphenylsilanyloxy)-hept-1-ene (16c): According to the general
procedure, reaction of ketone 8c (170 mg, 0.50 mmol) with 2 (80 mg,
0.25 mmol) gave the homoallylic ether 16c (62 mg, 0.10 mmol, 41%) as
colorless needles, along with recovered 2 (35 mg, 0.11 mmol, 44%). M.p.
818C (pentane); [a]2D0 11.28 (c 0.5, CHCl3); 1H NMR (200 MHz,
CDCl3): d 0.87 (d, J 6.0 Hz, 3H), 0.91 (s, 3H), 0.91 (s, 9H), 1.10 (d, J
6.8 Hz, 3H), 1.53 (dd, J1 7.2 Hz, Jl 14.5 Hz, 1H), 1.75 (dd, J1 6.0 Hz,
J2 14.4 Hz, 1H), 2.24 (ddd, J1 1.0 Hz, J2 7.0 Hz, J3 14.0 Hz, 1H), 2.36
(ddd, J1 1.0 Hz, J2 7.5 Hz, J3 14.0 Hz, 1H), 3.84 ± 4.12 (m, 2H), 4.44 (d,
J 3.8 Hz, 1H), 4.94 ± 5.06 (m, 2H), 5.57 ± 5.81 (m, 1H), 6.30 (brd, J
8.0 Hz, 1H), 7.06 ± 7.36 (m, 15H); 13C NMR (50.3 MHz, CDCl3): d 17.05,
19.12, 24.40, 25.32, 27.00, 43.74, 49.86, 51.82, 66.89, 74.17, 78.25, 115.5 (q,
1JCF 288 Hz), 118.0, 126.5, 127.3, 127.6, 128.2, 129.4, 129.6, 134.2, 135.9,
(70 eV, CI): m/z (%): 683 (100) [MNH3H] ; C39H50O3NF3Si (665.35):
calcd C 70.40, H 7.57; found C 70.50, H 7.64.
(4S,1'S,2'S,1''R,3''R,4''R)-4-(2'-Trifluoroacetamido-1'-phenyl-propoxy)-4-
(3''-tert-butyldiphenylsilanyloxy-4''-methyl-cyclohexyl)-pent-1-ene (16a):
According to the general procedure, reaction of ketone 8a (197 mg,
0.50 mmol) with 2 (80 mg, 0.25 mmol) gave the homoallylic ether 16a
(60 mg, 0.09 mmol, 36%) as a highly viscous oil, along with recovered 2
(44 mg, 0.14 mmol, 55%). 1H NMR (200 MHz, CDCl3): d 0.61 (s, 3H),
0.64 ± 1.70 (m, 11H), 0.99 (d, J 6.5 Hz, 3H), 1.05 (s, 9H), 2.13 (m, 2H),
3.20 ± 3.31 (m, 1H), 3.96 (m, 1H), 4.44 (d, J 4.0 Hz, 1H), 4.85 ± 4.98 (m,
2H), 5.39 ± 5.55 (m, 1H), 6.24 (brd, J 8.0 Hz, 1H), 7.04 ± 7.71 (m, 15H);
2
141.2, 156.0 (q, JCF 37 Hz); IR (KBr): nÄ 3302, 3106, 3072, 3044, 2964,
2934, 2896, 2858, 1702, 1214, 1186, 1164, 1108, 1066, 916, 760, 704 cmꢁ1; MS
(70 eV, CI): m/z (%): 629 (100) [MNH3H] ; C35H44F3NO3Si (611.82):
calcd C 68.71, H 7.24; found C 68.49, H 7.20.
13C NMR (50.3 MHz, CDCl3): d 16.21, 19.34, 19.50, 21.87, 26.17, 27.02,
1
32.91, 36.40, 40.41, 40.56, 43.78, 51.55, 73.50, 78.72, 79.79, 115.8 (q, JCF
(4R,6S,1'R,2'R)-4-Methyl-4-(2'-trifluoroacetamido-1'-phenyl-propoxy)-6-
phenyl-hept-1-ene (19d): According to the general procedure, reaction of
ketone 8d (81 mg, 0.50 mmol) with ent-2 (80 mg, 0.25 mmol) and diiso-
propylketone (285 mg, 2.50 mmol) gave the homoallylic ether 19d (72 mg,
0.17 mmol, 67%) as colorless needles, along with recovered ent-2 (10 mg,
288 Hz), 117.9, 126.7, 127.6, 128.1, 128.2, 128.4, 129.3, 129.4, 133.6, 141.1,
2
156.4 (q, JCF 37 Hz); IR (film): nÄ 3330, 3134, 3072, 3030, 2972, 2934,
2894, 2860, 1722, 1210, 1166, 1112, 1078, 1028, 916, 756, 704 cmꢁ1; MS
(70 eV, CI): m/z (%): 683 (100) [MNH3H] .
30 mmol, 13%). M.p. 908C (pentane, tert-butyl methyl ether); [a]D20
(4R,6S,1'R,2'R)-4,6,10-Trimethyl-4-(2'-trifluoroacetamido-1'-phenyl-prop-
oxy)-undec-1-ene (19b): According to the general procedure, reaction of
ketone 8b (85.0 mg, 0.50 mmol) with ent-2 (80 mg, 0.25 mmol) gave the
homoallylic ether 19b (49 mg, 0.11 mmol, 44%) as colorless needles, along
with recovered ent-2 (23 mg, 0.70 mmol, 29%). M.p. 548C (pentane);
[a]2D0 ꢁ18.08 (c 0.5, CHCl3); 1H NMR (200 MHz, CDCl3): d 0.79 ±
1.03 (m, 12H), 1.06 ± 1.73 (m, 13H), 2.32 (m, 2H), 4.08 (m, 1H), 4.60 (d, J
3.5 Hz, 1H), 5.04 ± 5.10 (m, 2H), 5.70 ± 5.94 (m, 1H), 6.45 (brd, J 8.0 Hz,
1H), 7.20 ± 7.42 (m, 5H); 13C NMR (50.3 MHz, CDCl3): d 17.22, 22.00,
22.58, 22.73, 24.02, 24.94, 27.98, 28.66, 39.27, 39.44, 43.64, 47.48, 51.97, 74.37,
24.38 (c 0.5, CHCl3); 1H NMR (200 MHz, CDCl3): d 0.84 (s, 3H),
1.11 (d, J 7.0 Hz, 3H), 1.14 (d, J 7.0 Hz, 3H), 1.19 (dd, J1 14.5 Hz, J2
4.0 Hz, 1H), 1.97 (dd, J1 14.5 Hz, J2 8.5 Hz, 1H), 2.28 (ddd, J1 1.0 Hz,
J2 7.0 Hz, J3 13.5 Hz, 1H), 2.36 (dd, J1 1.0 Hz, J2 7.5 Hz, J3 13.5 Hz,
1H), 2.90 (m, 1H), 4.01 (m, 1H), 4.55 (d, J 4.0 Hz, 1H), 5.02 ± 5.12 (m,
2H), 5.67 ± 5.81 (m, 1H), 6.30 (brd, J 8.0 Hz, 1H), 7.10 ± 7.33 (m, 10H);
13C NMR (50.3 MHz, CDCl3): d 16.91, 24.41, 25.61, 35.87, 43.48, 47.64,
1
51.87, 74.44, 79.46, 115.9 (q, JCF 288 Hz), 118.2, 126.7, 127.0, 127.8, 128.3,
2
128.4, 134.1, 141.3, 148.7, 155.4 (q, JCF 37 Hz); IR: nÄ 3310, 3084, 3072,
3030, 2970, 2930, 2854, 1702, 1204, 1184, 1164, 1056, 918, 762, 700 cmꢁ1; MS
1
79.75, 115.7 (q, JCF 288 Hz), 118.1, 126.5, 127.7, 128.3, 134.3, 141.7, 156.4
2
(70 eV, CI): m/z (%): 451 (100) [MNH3H] .
(q, JCF 37 Hz); IR (KBr): nÄ 3306, 3078, 3034, 2958, 2928, 2870, 1702,
1568, 1208, 1188, 1164, 914, 756, 702 cmꢁ1; MS (70 eV, CI): m/z (%): 459
(4S,6S,1'S,2'S)-4-Methyl-4-(2'-trifluoroacetamido-1'-phenyl-propoxy)-6-
phenyl-hept-1-ene (16d): According to the general procedure, reaction of
ketone 8d (81 mg, 0.50 mmol) with 2 (80.0 mg, 250 mmol) and diisopropyl
ketone (285 mg, 2.50 mmol) gave the homoallylic ether 16d (72 mg,
0.17 mmol, 66%) as colorless needles along with 2 (8 mg, 0.02 mmol, 10%).
M.p. 728C; [a]2D0 ꢁ26.68 (c 0.5, CHCl3); 1H NMR (300 MHz, CDCl3):
d 0.81 (s, 3H, 4-CH3), 1.05 (d, J 6.8 Hz, 3H, 7-H3), 1.24 (d, J 7.2 Hz,
3H, 3'-H2), 1.77 (dd, J1 4.0 Hz, J2 14.5 Hz, 1H, 5-Ha), 2.00 (dd, J1
8.7 Hz, J2 14.5 Hz, 1H, 5-Hb), 2.28 (ddd, J1 1.0 Hz, J2 7.2 Hz, J3
13.9 Hz, 1H, 3-Ha), 2.36 (ddd, J1 1.0 Hz, J2 7.6 Hz, J3 13.9 Hz, 1H,
3-Hb), 3.00 (m, 1H, 6-H), 3.98 (m, 1H, 2'-H), 4.53 (d, J 3.8 Hz, 1H, 1'-H),
5.09 (m, 2H, 1-H2), 5.68 ± 5.82 (m, 1H, 2-H), 5.97 (brd, J 8.0 Hz, 1H,
(100) [MNH3H] , 900 (5) [2 Â MNH3H] ; C25H38F3NO2 (441.75):
calcd C 68.00, H 8.66; found: C 68.18, H 8.86.
(4S,6S,1'S,2'S)-4,6,10-Trimethyl-4-(2'-trifluoroacetamido-1'-phenyl-prop-
oxy)-undec-1-ene (16b): According to the general procedure, reaction of
ketone 8b (85 mg, 0.50 mmol) with
2 (80 mg, 0.25 mmol) gave the
homoallylic ether 16b (57 mg, 0.13 mmol, 52%) as colorless needles, along
with recovered 2 (28 mg, 0.09 mmol, 35%). M.p. 548C (pentane); [a]D20
24.38 (c 0.5, CHCl3); 1H NMR (200 MHz, CDCl3): d 0.80 ± 1.75 (m,
25H), 2.38 (m, 2H), 4.10 (m, 1H), 4.60 (d, J 4.0 Hz, 1H), 5.07 ± 5.12 (m,
2H), 5.71 ± 5.96 (m, 1H), 6.42 (brd, J 8.0 Hz, 1H), 7.18 ± 7.46 (m, 5H);
13C NMR (50.3 MHz, CDCl3): d 17.13, 22.11, 22.56, 22.70, 24.16, 24.87,
N-H), 7.12 ± 7.32 (m, 10H, phenyl-H); 13C NMR (50.3 MHz, CDCl3): d
1
27.97, 28.56, 39.19, 39.27, 43.86, 47.49, 51.90, 74.29, 79.74, 115.8 (q, JCF
1
2
16.72, 24.36, 25.81, 35.80, 43.08, 47.57, 51.59, 74.56, 79.23, 115.7 (q, JCF
288 Hz), 118.0, 126.6, 127.7, 128.2, 134.4, 141.5, 156.4 (q, JCF 37 Hz); IR
(KBr): nÄ 3310, 3106, 3080, 2964, 2932, 2870, 1704, 1640, 1202, 1160, 914,
288 Hz), 118.0, 126.6, 126.9, 128.0, 128.2, 128.4, 134.0, 141.6, 148.8, 156.1 (q,
2JCF 37 Hz); IR (KBr): nÄ 3340, 3080, 3028, 2968, 2930, 2872, 1704, 1454,
1206, 1178, 1158, 1108, 918, 764, 704 cmꢁ1; MS (70 eV, CI): m/z (%): 451
756, 700 cmꢁ1; MS (70 eV, CI): m/z (%): 459 (100) [MNH3H] , 900 (5)
[2 Â MNH3H] .
166
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 2001
0947-6539/01/0701-0166 $ 17.50+.50/0
Chem. Eur. J. 2001, 7, No. 1